Drug lookup
Drug reference

papaverine

Vasodilator · Erectile Dysfunction Agent

VasodilatorErectile Dysfunction Agent
CDSCO approved
EXCRETION
not curated
INTERACTIONS
12 major
SEVERE in our sources
PREGNANCY
C
FDA category + note
Top interactionssee all 12
  • AbarelixSevereDatabaseDDInter
  • AbirateroneSevereDatabaseDDInter
  • AdenosineSevereDatabaseDDInter
  • AlfuzosinSevereDatabaseDDInter

Mechanism

When injected directly into the corpus cavernosum, papaverine causes smooth muscle relaxation, leading to penile tumescence and erection.

Indications

erectile dysfunction (ED) (rarely used now)

Dosing

Adult
3–20 mg intracavernosally (with or without phentolamine)

Side effects

Serious
  • priapism (2–15% cases, can cause permanent damage)
  • penile fibrosis (with repeated injections)
  • local haematoma
  • infection
  • paresthesia
  • penile deviation

Pregnancy & lactation

Pregnancy

C

Drug interactions

Abarelix
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Abiraterone
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Adenosine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Alfuzosin
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Alimemazine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amiodarone
Severe
Database

Drug interaction classified as: synergy.

Source: DDInter

Amisulpride
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amitriptyline
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Amoxapine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Anagrelide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Apalutamide
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Apomorphine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Related guidelines

Other Vasodilator drugs

Ask House about papaverine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team